Jon Kafer joins Bridgewest Perth Pharma as the Chief Commercial Officer and President of LumaCina the Branded drug division focused on sterile injectable finished dose products.

During Jon’s nearly thirty-year career in the Pharmaceutical industry, he has held executive leadership roles within Teva, Novarits, Allergan and Akorn. Jon’s commercial experience includes working across multiple markets and channels including Branded Rx, Generic Rx, and Specialty products.

Jon also has extensive experience working collaboratively with all the various stakeholders within the pharmaceutical supply chain including National Wholesalers, Large retail pharmacy networks, Health Systems, Government networks and Managed Care organizations all of which play a key role within the Pharmaceutical market strategy.

Jon holds a Bachelor of Science degree from The Ohio State University and will split his time between the U.S. and Australia.